MXCT Latest Press Releases

-- January 12, 2026 --

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 8:05 AM

-- December 1, 2025 --

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO Business Wire 9:00 AM

-- November 12, 2025 --

MaxCyte Announces Planned CFO Transition in 2026 Globe Newswire 4:08 PM

MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance Globe Newswire 4:05 PM

-- November 5, 2025 --

MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance Globe Newswire 8:05 AM

-- October 8, 2025 --

MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025 Globe Newswire 8:05 AM

-- October 6, 2025 --

MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors Globe Newswire 8:05 AM

-- September 22, 2025 --

MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software